Search results
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a Belgian pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
Headquartered in Titusville, New Jersey, Janssen is named after Dr. Paul Janssen, a leading pharmaceutical researcher, pharmacologist and general practitioner. His company, Janssen Pharmaceutica, joined the Johnson & Johnson family of companies in 1961.
4 days ago · We’re Janssen, the pharmaceutical companies of Johnson & Johnson. At Janssen EMEA, we’re dedicated to tackling some of the most important public health issues across Europe, the Middle East and Africa.
4 days ago · We prioritize support for activities within Janssen’s areas of scientific interest that contribute to improved knowledge, practice and performance for healthcare providers and improved health outcomes for patients.
Dec 18, 2020 · Janssen Pharmaceutica NV, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (the Company), will provide up to 500 million doses of its investigational COVID-19 vaccine candidate as part of an agreement in principle with Gavi, The Vaccine Alliance (Gavi).
Oct 6, 2021 · Janssen is now moving its dengue program into clinical development. Data from the early-stage study suggest that an antiviral compound prevents the interaction between two viral proteins (NS3 and NS4B) that play an important role in the replication process of a virus, thereby stopping the ability of the virus to reproduce.
In 1961, Johnson & Johnson acquired Janssen Pharmaceutica, the innovative drug company and research lab focused on public health. The company was founded in 1953 by Belgian-born Dr. Paul Janssen, one of the century’s most creative and prolific drug developers.
People also ask
Who owns Janssen Pharmaceutica?
Who are Janssen and Ortho-McNeil Pharmaceuticals?
Who is Janssen Research & Development?
When did Janssen Pharmaceuticals start?
